PRA International buys Spanish CRO (clinical research organisation):
This article was originally published in Clinica
Executive Summary
PRA International, the McLean, Virginia-based clinical research organisation (CRO), has acquired Staticon International Espana, a Madrid-based CRO, to expand its international network. Spain and Portugal are important clinical trial locations, David Thomas, vice-president and managing director of PRA's European operations told Clinica. PRA International conducts clinical trials and related services across a network of offices in the US, the UK, France, Germany, Spain and Poland. It also has partnerships in Latin America, South Africa, Australia and Asia. Of the $138 million revenues it expects in 2002, around 40% will be derived from its multi-country clinical trials. PRA also offers a number of complementary activities, including digitisation of medical images and specialised testing.